tiprankstipranks
CytoMed Therapeutics Limited (GDTC)
NASDAQ:GDTC
US Market
GDTC
CytoMed Therapeutics Limited
RESEARCH TOOLSreports
Want to see GDTC full AI Analyst Report?

CytoMed Therapeutics Limited (GDTC) Financial Statements

23 Followers

CytoMed Therapeutics Limited Financial Overview

CytoMed Therapeutics Limited's market cap is currently $11.80M. The company's EPS TTM is $; its P/E ratio is -2.93; CytoMed Therapeutics Limited is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Mar 24Dec 22Dec 21
Income Statement
Total Revenue$ 248.27K$ 52.01K$ 290.56K$ 0.00$ 84.18K
Gross Profit$ -689.55K$ 52.38K$ 381.92K$ -81.03K$ 81.59K
Operating Income$ -3.52M$ -2.63M$ -3.20M$ -1.70M$ -1.40M
EBITDA$ -3.34M$ -1.79M$ -2.94M$ -1.10M$ -1.05M
Net Income$ -3.05M$ -1.88M$ -3.13M$ -2.27M$ -1.53M
Balance Sheet
Cash & Short-Term Investments$ 2.10M$ 3.64M$ 6.82M$ 1.18M$ 1.87M
Total Assets$ 7.98M$ 7.37M$ 9.37M$ 3.90M$ 4.51M
Total Debt$ 482.56K$ 339.20K$ 339.50K$ 3.15M$ 2.42M
Net Debt$ -1.61M$ -3.30M$ -6.48M$ 1.97M$ 553.08K
Total Liabilities$ 1.13M$ 749.76K$ 852.28K$ 3.46M$ 2.59M
Stockholders' Equity$ 6.54M$ 6.57M$ 8.52M$ 438.24K$ 1.92M
Cash Flow
Free Cash Flow$ -4.40M$ -3.01M$ -2.72M$ -1.40M$ -1.70M
Operating Cash Flow$ -3.70M$ -1.98M$ -2.68M$ -1.04M$ -1.27M
Investing Cash Flow$ 929.28K$ 494.59K$ -2.11M$ -353.37K$ -610.72K
Financing Cash Flow$ 208.65K$ -33.36K$ 8.16M$ 793.25K$ 3.09M
Currency in USD

CytoMed Therapeutics Limited Earnings and Revenue History

Income Statement >

CytoMed Therapeutics Limited Debt to Assets

Balance Sheet >

CytoMed Therapeutics Limited Cash Flow

Cash Flow >

CytoMed Therapeutics Limited Forecast EPS vs Actual EPS

Earnings >